Addictions, Drug & Alcohol Institute

Front Page


October 17, 2025

New ICD-10-CM Code for Cannabinoid Hyperemesis Syndrome: R11.16

New ICD-10-CM Code for Cannabinoid Hyperemesis Syndrome. What does this mean and why does it matter?

A new ICD-10-CM diagnosis code for Cannabinoid Hyperemesis Syndrome (CHS) went into effect on October 1, 2025. ICD-10-CM codes are used to classify different medical diagnoses, symptoms, and procedures in health records and for billing and claims processing. To date, most health systems have documented CHS using a combination of codes for nausea and vomiting, such…


October 16, 2025

New Videos in the Mental Health Topics for Non-Therapist Professionals Series

Mental Health Topics for Non-Therapist Professionals: Seeing and Interacting with Trauma

The Mental Health Topics for Non-Therapist Professionals series on the LearnAboutTreatment.org website, produced by the ADAI State Opioid Response Training Team, is for providers who work with people with a substance use disorder (SUD) but are not trained as mental health therapists. The goal is to boost knowledge of mental health issues, especially those common…


New Naloxone and Overdose Resources from the WA Department of Health

New Naloxone and Overdose Resources from WA DOH

The WA State Department of Health (DOH) has some new resources out about naloxone and overdose. Issue Brief: The Risks of High-Dose Naloxone Products and Nalmefene for Community Opioid Overdose Response In this issue brief, DOH provides a summary of the current data and their recommendations on opioid overdose reversal medication types and dosages. Key…


October 15, 2025

Upcoming Northwest ATTC Webinars: The Power of Affirming Care (Oct 29) and Gaming Disordered Clients (Nov 5)

person at laptop with screen reading "webinar"

Join the Northwest ATTC this fall for two back-to-back webinar sessions! Certificate of Attendance available to all attendees of the live sessions. The Power of Affirming Care in SUD Recovery October 29, 2025 | 12pm-1:pm PTRegister here!Sponsored by the Northwest ATTC and the Washington Recovery Alliance. Affirming care is more than a value—it is a vital…


October 14, 2025

RECORDING AVAILABLE: Pathways to Connection: Accessing Treatment for Opioid Use Disorder Across Washington State (Oct. 14, 2025)

Pathways to Connection: Accessing Treatment for OUD across WA State. October 14, 2025

The Bree Collaborative and UW Addictions, Drug & Alcohol Institute hosted a webinar, Pathways to Connection: Accessing Treatment for Opioid Use Disorder Across Washington State, on October 14, 2025. This webinar explored how individuals across Washington State access treatment for opioid use disorder (OUD), with a focus on the implementation of medications for opioid use disorder (MOUD) in a…


September 26, 2025

Carfentanil: What Are We Seeing in Washington State?

From the UW Center for Community-Engaged Drug Education, Epidemiology & Research at the Addictions, Drug & Alcohol Institute The DEA recently reported that more than 50,000 fake pharmaceutical pills were seized by law enforcement in Western Washington. The pills were labeled with “M30” and designed to look like oxycodone. In recent years such pills typically…


September 16, 2025

New ADAI Publication: Expanding the Contingency Management Workforce to Include Peer Specialists

New ADAI publication

Citation: Hartzler B, et al. Reason to expand the contingency management workforce: Coaching-to-criterion results for addiction professionals and peer specialists. Subst Use Addict 2025 (in press). [doi: 10.1177/29767342251363007] Contingency management (CM) is a type of behavior therapy that uses rewards to motivate people in treatment for substance use disorder. These rewards encourage positive treatment behaviors,…


September 8, 2025

CTN/ATTC Webinar: Characterizing and Enhancing Collegiate Recovery Programs (1.5 CME/CE; Sept 24, 11am PT)

Characterizing and Enhancing Collegiate Recovery Programs: Results from a Methodology Project, September 24, 2025, 11am-12:30pm PT (virtual). 1.5 CME & CE credits available!

Join the Northwest ATTC (at ADAI), the Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network for their next webinar: Characterizing and Enhancing Collegiate Recovery Programs: Results from a Methodology Project September 24, 2025, 11am – 12:30pm PTNoel Vest, PhD, Assistant Professor at Boston University School of Public Health1.5 CME/CE…


August 21, 2025

ADAI Small Grants: Fall Cycle is Open; Apply by October 15, 2025!

ADAI Small Grants, Fall cycle is open, apply by October 15

ADAI works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants research program, which awards funds to UW researchers for pilot studies and developmental research. Applications for the fall cycle are now being accepted; apply by 5pm PT October 15, 2025! Research funded through the small grants program has…


NEW from CEDEER: Stimulants and Health: A Handout and Guide for Care Teams

Stimulants and Health handout and guide

Methamphetamine and cocaine can have serious health effects, but there are steps people can take support their health when they’re using. ADAI’s Center for Community-Engaged Drug Education, Epidemiology & Research (CEDEER) has released a new handout, Stimulants and Health: Support for people who use cocaine and methamphetamine, that offers information on: An accompanying interactive guide is designed for…



Next page